Event Type
Disclosure
Voluntary
Variant
8-K
Other Events. On December 4, 2025, Merck & Co., Inc. (the “Company”) closed an underwritten public offering of $500,000,000 aggregate principal amount of Floati
Financial Statements and Exhibits. (d) Exhibits Exhibit 4.1 Floating Rate Notes due 2029 Officers’ Certificate of the Company dated December 4, 2025, including